In vitro findings show that antibacterial compounds lower MIC values in Streptococcus pneumoniae, indicating potential for effective treatment.
The allosteric site of penicillin-binding protein 2x (PBP2x), an essential enzyme of cell-wall biosynthesis of Streptococcus pneumoniae, was targeted in virtual screening of >2 M compounds. A benzimidazole-2-methanamine hit emerged, which exhibited a modest minimal-inhibitory concentration (MIC) of 32 mg·L⁻¹. A structure-activity campaign around the structural template resulted in evaluation of 96 compounds, leading to several analogs with MIC of ≤4 mg·L⁻¹. These compounds exhibited a broad-based bactericidal growth inhibition against 31 clinical strains of S. pneumoniae.
No takes yet. Share an insight, caveat, or question.
Dominguez-Cisneros et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: